BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PPARA
,
T cell differentiation
,
Breast Cancer
,
Stem cell
,
DNA fingerprint
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IER3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Translation regulation during macrophage activation
HEK293 cells expressing NOD2wt or NOD2L1007fsinsC stimulated by muramyl dipeptide
CD4+ and CD8+ T lymphocytes from chronic HCV-infected patients
Corneal endothelial cells of fetuses and adults
Explore Curated Studies Results
Literature
Most Relevant Literature
Immediate Early Response Gene X-1 (IEX-1) Mediates Ischemic Preconditioning-Induced Cardioprotection…
Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyop…
EGR2 is a gonadotropin-induced survival factor that controls the expression of IER3 in ovarian granu…
Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER…
IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for IER3
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ